Examining worldwide postmarketing suicides from biologics used for psoriasis with a focus on brodalumab: A cross-sectional analysis using the Food and Drug Administration Adverse Event Reporting System (FAERS).

Yeroushalmi, Samuel; Chung, Mimi; Bartholomew, Erin; Hakimi, Marwa; Koo, John

Yeroushalmi, Samuel; Chung, Mimi; Bartholomew, Erin; Hakimi, Marwa; Koo, John.

Afiliação

Yeroushalmi S; Department of Dermatology, University of California, San Francisco, San Francisco, California.
Chung M; Department of Dermatology, University of California, San Francisco, San Francisco, California.
Bartholomew E; Department of Dermatology, University of California, San Francisco, San Francisco, California.
Hakimi M; Department of Dermatology, University of California, San Francisco, San Francisco, California.
Koo J; Department of Dermatology, University of California, San Francisco, San Francisco, California.

JAAD Int ; 9: 119-121, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36248199

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prevalence_studies Idioma: En Revista: JAAD Int Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google